Allianz Asset Management
INO icon

Allianz Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

Allianz Asset Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,175
Closed -$582K – 1901
2020
Q3 		$582K Sell
4,175
-408
-9% -$85.1K ﹤0.01% 1573
2020
Q2 		$1.48M Buy
+4,583
New +$736K ﹤0.01% 1720
2018
Q3 		– Sell
-17,913
Closed -$843K – 2653
2018
Q2 		$843K Sell
17,913
-104
-0.6% -$5.74K ﹤0.01% 2281
2018
Q1 		$1.02M Sell
18,017
-305
-2% -$16.5K ﹤0.01% 2206
2017
Q4 		$908K Sell
18,322
-242
-1% -$15K ﹤0.01% 2265
2017
Q3 		$1.41M Buy
18,564
+2,054
+12% +$153K ﹤0.01% 2127
2017
Q2 		$1.55M Buy
16,510
+935
+6% +$80K ﹤0.01% 2071
2017
Q1 		$1.24M Buy
15,575
+4,359
+39% +$347K ﹤0.01% 2171
2016
Q4 		$934K Sell
11,216
-1,466
-12% -$133K ﹤0.01% 2230
2016
Q3 		$1.42M Buy
12,682
+1,311
+12% +$145K ﹤0.01% 2106
2016
Q2 		$1.26M Buy
+11,371
New +$1.38M ﹤0.01% 2100

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management's INO Position: Q4 2020 in Review

Allianz Asset Management sold out of Inovio Pharmaceuticals (INO) in Q4 2020, closing a stake of 4,175 shares — an estimated $582K sold.

Allianz Asset Management first reported a position in INO in Q2 2016 and held it in 11 quarters. The position peaked at $1.55M in Q2 2017. 227 funds tracked by Wall St. Rank hold INO as of Q4 2020.

  • Allianz Asset Management reported no remaining Inovio Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Allianz Asset Management sold 4,175 Inovio Pharmaceuticals shares in Q4 2020, an estimated $582K.
  • Allianz Asset Management first reported a position in Inovio Pharmaceuticals in Q2 2016 and held it in 11 quarters.
  • Allianz Asset Management's Inovio Pharmaceuticals position peaked at $1.55M in Q2 2017.
  • 227 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2020.

Based on Allianz Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.